Astellas Pharma Inc.
Get $10 bonus on your first $100 deposit for ALPMY
Get $10 bonus on your first $100 deposit for ALPMY
Astellas Pharma Inc. (ALPMY) Stock Competitors & Peer Comparison
See (ALPMY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALPMY | $16.43 | -2.07% | 29.5B | 38.33 | $0.43 | +2.97% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.19% |
| RHHBF | $406.38 | +3.82% | 331.3B | 20.71 | $20.10 | +2.25% |
| RHHBY | $50.12 | -0.56% | 321.1B | 19.86 | $2.51 | +2.01% |
| RHHVF | $403.29 | +8.69% | 321B | 19.93 | $20.24 | +3.09% |
| NVSEF | $154.88 | +6.45% | 295.5B | 21.69 | $7.14 | +1.99% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.68% |
| SNYNF | $95.27 | +1.00% | 114.6B | 20.40 | $4.67 | +4.63% |
| GLAXF | $26.55 | -2.57% | 107B | 14.54 | $1.84 | +3.30% |
| CHGCY | $27.78 | -5.09% | 95.1B | 34.82 | $0.83 | +2.84% |
Stock Comparison
ALPMY vs BMYMP Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, ALPMY is priced at $16.43, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, ALPMY's ROE is +0.20%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, ALPMY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check BMYMP's competition here
ALPMY vs RHHBF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, RHHBF has a market cap of 331.3B. Regarding current trading prices, ALPMY is priced at $16.43, while RHHBF trades at $406.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas RHHBF's P/E ratio is 20.71. In terms of profitability, ALPMY's ROE is +0.20%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, ALPMY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check RHHBF's competition here
ALPMY vs RHHBY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, RHHBY has a market cap of 321.1B. Regarding current trading prices, ALPMY is priced at $16.43, while RHHBY trades at $50.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas RHHBY's P/E ratio is 19.86. In terms of profitability, ALPMY's ROE is +0.20%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, ALPMY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check RHHBY's competition here
ALPMY vs RHHVF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, ALPMY is priced at $16.43, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas RHHVF's P/E ratio is 19.93. In terms of profitability, ALPMY's ROE is +0.20%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, ALPMY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check RHHVF's competition here
ALPMY vs NVSEF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, NVSEF has a market cap of 295.5B. Regarding current trading prices, ALPMY is priced at $16.43, while NVSEF trades at $154.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas NVSEF's P/E ratio is 21.69. In terms of profitability, ALPMY's ROE is +0.20%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, ALPMY is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check NVSEF's competition here
ALPMY vs AZNCF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, ALPMY is priced at $16.43, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, ALPMY's ROE is +0.20%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, ALPMY is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check AZNCF's competition here
ALPMY vs SNYNF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, SNYNF has a market cap of 114.6B. Regarding current trading prices, ALPMY is priced at $16.43, while SNYNF trades at $95.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas SNYNF's P/E ratio is 20.40. In terms of profitability, ALPMY's ROE is +0.20%, compared to SNYNF's ROE of +0.15%. Regarding short-term risk, ALPMY is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check SNYNF's competition here
ALPMY vs GLAXF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, GLAXF has a market cap of 107B. Regarding current trading prices, ALPMY is priced at $16.43, while GLAXF trades at $26.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas GLAXF's P/E ratio is 14.54. In terms of profitability, ALPMY's ROE is +0.20%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, ALPMY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check GLAXF's competition here
ALPMY vs CHGCY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, CHGCY has a market cap of 95.1B. Regarding current trading prices, ALPMY is priced at $16.43, while CHGCY trades at $27.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas CHGCY's P/E ratio is 34.82. In terms of profitability, ALPMY's ROE is +0.20%, compared to CHGCY's ROE of +0.23%. Regarding short-term risk, ALPMY is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CHGCY's competition here
ALPMY vs CHGCF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, CHGCF has a market cap of 91.5B. Regarding current trading prices, ALPMY is priced at $16.43, while CHGCF trades at $55.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas CHGCF's P/E ratio is 33.49. In terms of profitability, ALPMY's ROE is +0.20%, compared to CHGCF's ROE of +0.22%. Regarding short-term risk, ALPMY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check CHGCF's competition here
ALPMY vs BAYRY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, BAYRY has a market cap of 44.2B. Regarding current trading prices, ALPMY is priced at $16.43, while BAYRY trades at $11.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas BAYRY's P/E ratio is -10.62. In terms of profitability, ALPMY's ROE is +0.20%, compared to BAYRY's ROE of -0.12%. Regarding short-term risk, ALPMY is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check BAYRY's competition here
ALPMY vs OTSKY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, OTSKY has a market cap of 38.6B. Regarding current trading prices, ALPMY is priced at $16.43, while OTSKY trades at $35.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas OTSKY's P/E ratio is 16.57. In terms of profitability, ALPMY's ROE is +0.20%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, ALPMY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OTSKY's competition here
ALPMY vs OTSKF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, OTSKF has a market cap of 38.1B. Regarding current trading prices, ALPMY is priced at $16.43, while OTSKF trades at $72.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas OTSKF's P/E ratio is 14.92. In terms of profitability, ALPMY's ROE is +0.20%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, ALPMY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OTSKF's competition here
ALPMY vs DSNKY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, DSNKY has a market cap of 33.9B. Regarding current trading prices, ALPMY is priced at $16.43, while DSNKY trades at $17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas DSNKY's P/E ratio is 19.71. In terms of profitability, ALPMY's ROE is +0.20%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, ALPMY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check DSNKY's competition here
ALPMY vs DSKYF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, DSKYF has a market cap of 33.9B. Regarding current trading prices, ALPMY is priced at $16.43, while DSKYF trades at $18.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas DSKYF's P/E ratio is 19.70. In terms of profitability, ALPMY's ROE is +0.20%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, ALPMY is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check DSKYF's competition here
ALPMY vs ALPMF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, ALPMF has a market cap of 31.5B. Regarding current trading prices, ALPMY is priced at $16.43, while ALPMF trades at $16.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas ALPMF's P/E ratio is 40.93. In terms of profitability, ALPMY's ROE is +0.20%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, ALPMY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check ALPMF's competition here
ALPMY vs ORINY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, ORINY has a market cap of 21.4B. Regarding current trading prices, ALPMY is priced at $16.43, while ORINY trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas ORINY's P/E ratio is 18.44. In terms of profitability, ALPMY's ROE is +0.20%, compared to ORINY's ROE of +0.47%. Regarding short-term risk, ALPMY is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check ORINY's competition here
ALPMY vs CSPCY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, CSPCY has a market cap of 14.7B. Regarding current trading prices, ALPMY is priced at $16.43, while CSPCY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas CSPCY's P/E ratio is 25.50. In terms of profitability, ALPMY's ROE is +0.20%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, ALPMY is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check CSPCY's competition here
ALPMY vs GIKLY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, GIKLY has a market cap of 13.6B. Regarding current trading prices, ALPMY is priced at $16.43, while GIKLY trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas GIKLY's P/E ratio is 16.19. In terms of profitability, ALPMY's ROE is +0.20%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, ALPMY is less volatile compared to GIKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check GIKLY's competition here
ALPMY vs CHJTF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, CHJTF has a market cap of 11.7B. Regarding current trading prices, ALPMY is priced at $16.43, while CHJTF trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas CHJTF's P/E ratio is 20.40. In terms of profitability, ALPMY's ROE is +0.20%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, ALPMY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CHJTF's competition here
ALPMY vs ORINF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, ORINF has a market cap of 11.6B. Regarding current trading prices, ALPMY is priced at $16.43, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas ORINF's P/E ratio is 20.23. In terms of profitability, ALPMY's ROE is +0.20%, compared to ORINF's ROE of +0.47%. Regarding short-term risk, ALPMY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check ORINF's competition here
ALPMY vs RCDTF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, RCDTF has a market cap of 11.6B. Regarding current trading prices, ALPMY is priced at $16.43, while RCDTF trades at $56.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas RCDTF's P/E ratio is 23.24. In terms of profitability, ALPMY's ROE is +0.20%, compared to RCDTF's ROE of +0.21%. Regarding short-term risk, ALPMY is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check RCDTF's competition here
ALPMY vs GIFLF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, GIFLF has a market cap of 8.8B. Regarding current trading prices, ALPMY is priced at $16.43, while GIFLF trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas GIFLF's P/E ratio is 20.48. In terms of profitability, ALPMY's ROE is +0.20%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check GIFLF's competition here
ALPMY vs GIFOF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, ALPMY is priced at $16.43, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas GIFOF's P/E ratio is 13.83. In terms of profitability, ALPMY's ROE is +0.20%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check GIFOF's competition here
ALPMY vs OPHLY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, OPHLY has a market cap of 7.5B. Regarding current trading prices, ALPMY is priced at $16.43, while OPHLY trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas OPHLY's P/E ratio is 23.00. In terms of profitability, ALPMY's ROE is +0.20%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OPHLY's competition here
ALPMY vs OPHLF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, ALPMY is priced at $16.43, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas OPHLF's P/E ratio is 20.49. In terms of profitability, ALPMY's ROE is +0.20%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OPHLF's competition here
ALPMY vs KYKOF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, KYKOF has a market cap of 6.5B. Regarding current trading prices, ALPMY is priced at $16.43, while KYKOF trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas KYKOF's P/E ratio is 15.33. In terms of profitability, ALPMY's ROE is +0.20%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check KYKOF's competition here
ALPMY vs DPHAY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, ALPMY is priced at $16.43, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, ALPMY's ROE is +0.20%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, ALPMY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check DPHAY's competition here
ALPMY vs SNPHY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, SNPHY has a market cap of 3.7B. Regarding current trading prices, ALPMY is priced at $16.43, while SNPHY trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas SNPHY's P/E ratio is 19.81. In terms of profitability, ALPMY's ROE is +0.20%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, ALPMY is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check SNPHY's competition here
ALPMY vs SNPHF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, ALPMY is priced at $16.43, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas SNPHF's P/E ratio is 18.95. In terms of profitability, ALPMY's ROE is +0.20%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, ALPMY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check SNPHF's competition here
ALPMY vs VRBCF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, VRBCF has a market cap of 3.2B. Regarding current trading prices, ALPMY is priced at $16.43, while VRBCF trades at $384.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas VRBCF's P/E ratio is 18.59. In terms of profitability, ALPMY's ROE is +0.20%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, ALPMY is less volatile compared to VRBCF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check VRBCF's competition here
ALPMY vs HAWPY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, ALPMY is priced at $16.43, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas HAWPY's P/E ratio is 14.34. In terms of profitability, ALPMY's ROE is +0.20%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, ALPMY is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check HAWPY's competition here
ALPMY vs PTKFF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, PTKFF has a market cap of 2.7B. Regarding current trading prices, ALPMY is priced at $16.43, while PTKFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas PTKFF's P/E ratio is N/A. In terms of profitability, ALPMY's ROE is +0.20%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, ALPMY is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check PTKFF's competition here
ALPMY vs HAWPF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, ALPMY is priced at $16.43, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas HAWPF's P/E ratio is 12.90. In terms of profitability, ALPMY's ROE is +0.20%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, ALPMY is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check HAWPF's competition here
ALPMY vs CMOPF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, CMOPF has a market cap of 1.8B. Regarding current trading prices, ALPMY is priced at $16.43, while CMOPF trades at $109.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas CMOPF's P/E ratio is -419.23. In terms of profitability, ALPMY's ROE is +0.20%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, ALPMY is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check CMOPF's competition here
ALPMY vs LYPHF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, LYPHF has a market cap of 1.5B. Regarding current trading prices, ALPMY is priced at $16.43, while LYPHF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas LYPHF's P/E ratio is 18.88. In terms of profitability, ALPMY's ROE is +0.20%, compared to LYPHF's ROE of +0.03%. Regarding short-term risk, ALPMY is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check LYPHF's competition here
ALPMY vs TGRNF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, ALPMY is priced at $16.43, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, ALPMY's ROE is +0.20%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, ALPMY is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check TGRNF's competition here
ALPMY vs JCRRF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, ALPMY is priced at $16.43, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, ALPMY's ROE is +0.20%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, ALPMY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check JCRRF's competition here
ALPMY vs MAYNF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, MAYNF has a market cap of 134.1M. Regarding current trading prices, ALPMY is priced at $16.43, while MAYNF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas MAYNF's P/E ratio is -2.32. In terms of profitability, ALPMY's ROE is +0.20%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, ALPMY is less volatile compared to MAYNF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check MAYNF's competition here
ALPMY vs PTKFY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, PTKFY has a market cap of 13.1M. Regarding current trading prices, ALPMY is priced at $16.43, while PTKFY trades at $11.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas PTKFY's P/E ratio is 12.15. In terms of profitability, ALPMY's ROE is +0.20%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, ALPMY is less volatile compared to PTKFY. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check PTKFY's competition here
ALPMY vs PSYGF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, ALPMY is priced at $16.43, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, ALPMY's ROE is +0.20%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, ALPMY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check PSYGF's competition here
ALPMY vs CRXTQ Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 29.5B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, ALPMY is priced at $16.43, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 38.33, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, ALPMY's ROE is +0.20%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, ALPMY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CRXTQ's competition here